Acquisitions and Equity Method Investments |
12 Months Ended |
---|---|
Jul. 31, 2025 | |
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] | |
Acquisitions and Equity Method Investments | Note 2. Acquisitions and Equity Method Investments Acquisitions There have been no material acquisitions in fiscal 2025 or 2024. Equity Method Investments On August 9, 2024, the Company acquired a 49% non-controlling stake in Medica, headquartered in Medolla, Italy, for cash consideration of approximately €62.1 million, or $67.9 million and capitalized transaction costs of approximately €5.1 million, or $5.8 million. Medica is a leader in hollow fiber membrane filtration technology for medical applications and water purification. The Company has the option to acquire the remaining 51% stake in three years. The investment is accounted for under the equity method of accounting. The earnings from the investment were not material for the year ended July 31, 2025.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The entire disclosure for business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|